ArticleIndian journal of pediatrics2025
Genotype Diversity of Rotavirus in Odisha, India: Postvaccine Changes.
Article in Indian journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe inclusion of the ROTAVAC
methodsClinical data and vaccination records of children aged < 5 y with AGE enrolled across multiple tertiary centers in Odisha were collected through hospital-based surveillance. Stool samples were collected and tested for rotavirus antigen using enzyme immunoassay. Positive samples were genotyped using reverse transcription-polymerase chain reaction.
resultsOf the 6,233 stool samples tested, 37.1% were positive for rotavirus. Positivity declined from 60.2% in 2014 to 23.3% in 2023, representing a 61.3% relative reduction. A significant shift in genotype prevalence was observed after vaccine introduction. G1P[8], the predominant strain in the prevaccine era (45.6%), decreased in prevalence and disappeared after 2018. G3P[8] emerged as a predominant strain during the postvaccination period, and G2P[4] resurged, representing 40.9% of cases in 2023. Mixed infections constituted 14.8% of samples, highlighting ongoing genetic diversity.
conclusionsThe introduction of rotavirus vaccines has reduced the prevalence of rotavirus infections and altered the rotavirus genotype distribution in Odisha. The predominance of G3P[8] and resurgence of G2P[4] indicate evolving strain dynamics after vaccine introduction. This study, thus, highlights the importance of vaccination programs in mitigating rotavirus-associated morbidity, emphasizing the need for sustained monitoring to guide future vaccine strategies.
Indexed as
Identifiers
41165920What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.